VR Adviser »

Praxis Precision Medicines I shares owned by VR Adviser

Quarter-by-quarter ownership of Praxis Precision Medicines I (PRAX) shares owned by VR Adviser from 13F filings

Historical chart of VR Adviser investment in Praxis Precision Medicines I

Tip: Access up to 7 years of quarterly data

All positions including Praxis Precision Medicines I held by VR Adviser consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Praxis Precision Medicines I by VR Adviser

Quarter filed Position value Share count Share price at filing
2023-12-31 $7.9M 354k 22.28

More positions owned by VR Adviser

Rayzebio
Apogee Therapeutics (APGE)
Pharvaris N V (PHVS)
Miragen Therapeutics (VRDN)
4d Molecular Therapeutics In (FDMT)
Merus N V (MRUS)
Cabaletta Bio (CABA)
Spyre Therapeutics Com New (SYRE)
Kalvista Pharmaceuticals (KALV)
Enliven Therapeutics (ELVN)
Ocular Therapeutix (OCUL)
Hillevax (HLVX)
Ambrx Biopharma
Terns Pharmaceuticals (TERN)
Dyne Therapeutics (DYN)

View all positions for VR Adviser

Top funds holding Praxis Precision Medicines I

Point72 Asset Management
Partner Fund Management
Cormorant Asset Management
Vanguard Group
VR Adviser
Kingdon Capital Management
Bank of America Corporation
Tri Locum Partners
Ikarian Capital
Assenagon Asset Management
Blackstone Group
Jacobs Levy Equity Management
72 Investment Holdings
Citadel Advisors
Marshall Wace

View all funds holding Praxis Precision Medicines I